Elicio Therapeutics Inc. logo

ELTX

Elicio Therapeutics Inc. · NASDAQ

Market cap
$41.9M

Elicio Therapeutics Inc. (ELTX) is a Biotechnology: Pharmaceutical Preparations company listed on NASDAQ. In the last 30 days Quantisnow tracked 7 wire items for ELTX, including 3 press releases and news items, 3 SEC filings and 1 earnings update. The most recent was published Nov 13, 2026.

ELTX rankings

Financial highlights

Full financials
Net income, TTM
-$35.74M
Cash
$30.90M

For the twelve months ended Sep 30, 2026, from SEC filings. Not investment advice.

News · 26 weeks41+200%
2026-05-24: 02026-05-31: 12026-06-07: 12026-06-14: 52026-06-21: 12026-06-28: 42026-07-05: 22026-07-12: 42026-07-19: 02026-07-26: 02026-08-02: 02026-08-09: 42026-08-16: 02026-08-23: 12026-08-30: 82026-09-06: 02026-09-13: 12026-09-20: 12026-09-27: 02026-10-04: 12026-10-11: 02026-10-18: 12026-10-25: 12026-11-01: 42026-11-08: 12026-11-15: 0
2026-05-242026-11-15
Mix1990d
  • Insider7(37%)
  • Other6(32%)
  • SEC Filings5(26%)
  • Earnings1(5%)
Activity · 52 weeks7143 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news

Latest news

25 items

ELTX FAQ

9 questions
  • What is the latest news on ELTX?
    In the last 30 days Quantisnow tracked 7 wire items for ELTX: 3 press releases and news items, 3 SEC filings and 1 earnings update. The most recent was published on November 13, 2026.
  • Is ELTX profitable?
    No. Elicio Therapeutics Inc. reported a net loss of $35.74M for the twelve months ended Sep 30, 2026.
  • How much cash and debt does ELTX have?
    Elicio Therapeutics Inc. reported $30.90M in cash and cash equivalents and $9.63M of debt on its most recent balance sheet in SEC filings.
  • Where does ELTX stock trade?
    Elicio Therapeutics Inc. (ELTX) is listed on NASDAQ.
  • What sector and industry is ELTX in?
    Elicio Therapeutics Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.
  • When did Elicio Therapeutics Inc. go public?
    Elicio Therapeutics Inc. (ELTX) completed its IPO in 2021.
  • What are analysts saying about ELTX?
    Elicio Therapeutics Inc. has had 4 recent analyst actions on file. The most recent action was from Ladenburg Thalmann: Buy with a $12.00 price target on 2026-06-18. Recent price targets range from $12.00 to $27.00.
  • What companies are similar to ELTX?
    Notable peers in the same industry include ABT (Abbott Laboratories), JNJ (Johnson & Johnson), MRK (Merck & Company Inc.), NVO (Novo Nordisk A/S), AZN (AstraZeneca PLC). Compare ELTX side-by-side with any of them on Quantisnow.
  • How can I track ELTX on Quantisnow?
    Quantisnow aggregates Elicio Therapeutics Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ELTX to receive live email and push alerts on every new disclosure.